KT
Kallum Titchmarsh Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
11
Avg Return
Past Year
Past Year
6.6%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
33.3%
Neutral
66.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Healthcare
Healthcare
Diagnostics & Research
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Equal-Weight
Initiated
| $285 |
1%
upside
| 1 | – |
–
| 2 Dec ‘25 2 days ago |
|
|
|
Equal-Weight
Initiated
| $423 |
7%
upside
| 1 | – |
–
| 2 Dec ‘25 2 days ago |
|
|
|
Equal-Weight
Initiated
| $1,550 |
9%
upside
| 1 | – |
–
| 2 Dec ‘25 2 days ago |
|
|
|
Equal-Weight
Downgraded
| $130 |
8%
downside
| 1 | -11% |
0
%
| 2 Dec ‘25 2 days ago |
|
|
|
Overweight
Initiated
| $270 |
19%
upside
| 1 | +1.6% |
0
%
| 2 Dec ‘25 2 days ago |
|
|
|
Overweight
Initiated
| $180 |
22%
upside
| 1 | -1.5% |
0
%
| 2 Dec ‘25 2 days ago |
|